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Abstract 
The present study aims to provide a detailed protocol to obtain an aged cell culture model, which is conveniently 
characterised in terms of morphology, metabolism, and key biochemical markers of senescence. Commercial Human Dermal 
Fibroblasts (HDF) (67-year-old female Asian donor) were cultured over a span of 35 passages to determine at what passages 
they express the phenotypes found in vivo in the geriatric population. The growth rate and density (counting, Trypan Blue) at 
confluence declined 4- and 3-fold, respectively. During 15 passages in vitro ageing the fibroblast metabolic capacity (XTT) 
was heavily reduced (by 75%), while conversely the content of cellular proteins (SRB) slightly increased (2 fold). Senescent 
cells (SA-β-gal positive) were continuously emerging from 0 to 20%. Freezing/thawing at this stage restored metabolic 
performance to original values which declined at a similar rate as before. Passages 5 - 10 of our selected aged HDFs were 
found to mimic in vivo tissue of older adults to the greatest extent. 
 
Rezumat 
Scopul studiului este de a furniza un protocol de obținere al unui model de cultură celulară senescentă, caracterizat în mod 
convenabil din punct de vedere morfologic, metabolic și al expresiei markerilor biochimici caracteristici senescenței. 
Fibroblaste dermice umane disponibile comercial (HDF) (donator asiatic de sex feminin de 67 de ani) au fost cultivate într-o 
succesiune de 35 de pasaje pentru a determina cu exactitate când se exprimă fenotipurile in vivo în populația geriatrică. Rata 
de creștere și densitatea la confluență au scăzut de 4 ori și, respectiv, de 3 ori. Pe parcursul a 15 pasaje, capacitatea 
metabolică a fibroblastelor a fost redusă puternic (cu 75%), în timp ce conținutul de proteine celulare a crescut ușor (de 2 
ori). Celulele senescente (SA-β-gal pozitive) au apărut în mod continuu cu până la 20%. Înghețarea/dezghețarea în această 
etapă au restabilit performanța metabolică la valorile inițiale, care au scăzut la o rată similară cu cea inițială. S-a constatat că 
pasajele 5 - 10 ale celulelor îmbătrânite mimează într-o mare măsură țesutul in vivo al adulților în vârstă. 
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Introduction 
The world population is undergoing a demographic 
shift and life expectancy is continuously increasing 
[1]. Consequently, older adults (i.e. aged > 65) are 
the group consuming the majority of medicines [2]. 
Along with various disabilities and illnesses elderly 
patients might be suffering from, they represent a 
very heterogeneous population [1]. The process of 
ageing impacts on a transient loss of physiological, 
tissue, cellular, and molecular functionality of cells and 
tissues, resulting in altered kinetics of the administered 
drugs, which can be expressed to different extents 
[3]. However, not all medicines are tailored to their 
needs specifically [2]. In recent years, formulations 
suitable for geriatric subpopulations have been 
gaining more attention [4-7]. In the design of drug 
delivery systems, changes that result from ageing at 
a cellular level are often not considered [3]. 
Conventional safety and efficacy test models, such as 
animal experiments or static in vitro systems, ranging 
from classic two-dimensional monolayer cell culture 
models to newer biodynamic imaging in three-
dimensional cell or tissue models, and “organotypic 
slice-on-chop” procedures do not imitate relevant 
features of these patients yet [8-10]. Therefore, with 
novel formulations being developed in particular for 
older patients in the era of personalized medicine, 
the need for a new cell culture model mimicking as 
closely as possible physiological conditions of the 
aged population was acknowledged. Such a model 
was hypothesised to be useful during drug discovery 
and preclinical studies to determine cytotoxicity and 
efficacy of active pharmaceutical ingredients and 
formulations. 
The aim of this study is to investigate how it can be 
replicated in vitro the age-related changes that occur 
in vivo. The changes that occur in human cells 
progressively are almost impossible to mimic in in 
vivo studies but is reasonable to follow molecular 
events in cellular culture [11]. It is generally accepted 
that somatic, or at least proliferating cells, preserve 
the ability to undergo cellular senescence, which is 
defined as a permanent proliferative cell cycle arrest 
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that is resistant to growth factors and other signals 
that induce cell proliferation [12]. Human cells are 
capable of roughly 50 population doublings only. 
This phenomenon, known as the ‘Hayflick limit’, 
occurs when an entire cell population enters 
senescence [11, 13], where cell “reprogramming” 
finalises not only in permanent growth arrest, but 
also in changed morphology and function [12]. Apart 
from an inability to divide in optimal environmental 
conditions, senescent cells are larger in size, have 
different morphology, altered gene expression and 
acquire the senescence-associated secretory phenotype 
(SASP) [14-17]. Senescent cells are often found in 
the tissue of elderly, while very rarely in young 
tissue [14, 18]. It is assumed that senescent cells 
negatively impact neighbouring cells through their 
SASP, thus contributing to higher susceptibility to 
pathological changes [13, 14, 18, 19]. 
Among different types of cells, primary cells preserve 
most of the characteristics from the tissue when grown 
in vitro [20]. Immortalised cell lines undergo several 
mutations to escape senescence leading to a significant 
change in their phenotype and were thus deemed 
inappropriate for our study. Fibroblasts were the 
first cells successfully cultured in laboratory and are 
today the most extensively used cell culture for 
research involving cell ageing [13, 15] and interactions 
with delivery systems [21, 22]. Additionally, they 
are extremely easy to culture in vitro [23, 24], thus 
being appropriate for any cell laboratory. Based on 
their wide availability and long history of use, human 
dermal fibroblasts were selected for the development 
of the presented aged cell culture model. 
To our knowledge, no attempt to develop an aged 
cell culture model for preliminary safety screening 
of drug delivery systems or active pharmaceutical 
ingredients has been described to date. This study 
aimed to explore if an aged cell culture model may 
mimic the characteristics of older people by investigating 
the effect of cell culture age on cell morphology, 
maximal growth rate, density at confluence, occurrence 
of senescent cells and cell viability. 
 
Materials and Methods 
Materials 
Human Dermal Fibroblasts (HDF) from a 67-year-old 
female Asian donor were obtained from Life Tech. 
(Cat. No. C0135C, Lot 771555) (Carlsbad, CA, USA). 
Cell culture media and supplements were supplied by 
Sigma-Aldrich (St. Louis, MO, USA). 2,3-Bis(2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide inner salt (XTT, 90%) was supplied by 
Alfa Aesar (Karlsruhe, Germany). All other reagents 
were cell culture grade and from Sigma-Aldrich® 
(St. Louis, MO, USA). 
Cell culture 
HDFs were cultured as adherent monolayers in 
humidified air with 5% CO2 and 37ºC in Dulbecco’s 
Modified Eagle’s Medium (Dulbecco’s MEM, DMEM) 
supplemented with 10% foetal bovine serum, 2 mM 
L-glutamine, 1% MEM non-essential amino acid 
solution, 10 µg/mL gentamicin and 0.25 µg/mL 
amphotericin B. Cells were seeded in 5 mL/25 cm2 
growth media. After three to four days of growth cells 
were washed with phosphate buffered saline (PBS), 
detached with 1 mL/25 cm2 of Hanks’ balanced salt 
solution containing 0.05% porcine trypsin and 0.2 g/L 
Na4EDTA for 10 min and collected with 3 mL/25 cm2 
growth media. The cells were subcultured at 2 × 104 
cells/cm² upon reaching 80% confluence. After the 19th 
passage, cells were frozen in 5% dimethyl sulfoxide 
in complete media in liquid nitrogen and after a 
fortnight thawed and seeded as described above. 
Cell counting 
Growth promotion was determined by counting cells 
using trypan blue solution and a haemocytometer. 
Cumulative population doublings of cells for each 
passage (D) was calculated using Equation 1 [25], 
where C = old passage doubling, n = largest natural 
number that satisfies equation A (2n) ≤ B, B = 
number of cells counted at end of growth period 
and A = number of cells plated at the beginning of 
the passage. Population doubling increment was 
divided by the period of growth to give an average 
growth rate for each passage.  𝐷 = 𝐶 + 𝑛 +  !!!(!!)!(!!!!! !!) (Equation 1) 
Additionally, every second passage, cells were seeded 
at 8.0 x 104 cells/well on 12-well plates to determine 
maximal growth rate and density at confluence (Table 
I). Growth media was changed every 3 days. After 
1, 2, 3 and 6 days, cells were detached and counted 
on the haemocytometer. The maximal growth rate 
was calculated from the exponential phase of growth 
(days 1 - 3) for each passage and expressed as number 
of times population doubled in 1 day ± SE. Density at 
confluence was determined after 6 days of growth. 
The values are presented as mean ± SD of 4 
determinations. 
Table I 
Protocol to determine maximal growth rate and density at confluence 
Step Parameter Value Description 
1 Plate cells 1,000 µL 80,000 HDF cells in complete media, 12-well 
plate 
2 Incubation time 24 h 37°C, 5% CO2 
3 Ca2+- and Mg2+-free Dulbecco’s Phosphate Buffered Saline 1,000 µL Wash cells 
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Step Parameter Value Description 
4 0.05% porcine trypsin, 0.2 g/L Na4EDTA in Hanks’ 
Balanced Salt Solution 
150 µL Detach cells 
5 Incubation time 20 min 37°C, 5% CO2 
6 Counting cells At least 
250 
Load on haemocytometer and examine under 
the microscope 
7 Calculate cell density 4 wells  
8 Incubation time 24, 48, 
120 h 
37°C, 5% CO2 
9 Repeat steps 3 - 7 for all time points in 8 4 wells  
Step notes: (1) Complete media: 10% foetal bovine serum, 2 mM L-glutamine, 1 % MEM non-essential amino acid solution, 10 µg/mL 
gentamicin and 0.25 µg/mL amphotericin B in DMEM; (4) 4 wells; (7) 𝐶𝑒𝑙𝑙 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 = !° !" !"##$ !" ! !"#$%&!.! !!   !"# !!!.! !"!. 
 
Cell morphology 
The cell morphology was assessed directly from cell 
culture using an Evos FL (Life Technologies Carlsbad, 
CA, USA) inverted light microscope under the 10×, 
20× and 40× magnification. 
Cell density and proliferation 
Cell density was measured by staining cells for protein 
content according the sulforhodamine B (SRB) method 
[26, 27]. The supernatant was removed; cells were 
washed with phosphate saline buffer (PBS) and fixed 
with a mixture of 100 µL phenol red-free DMEM 
and 100 µL cold 10% trichloroacetic acid for 1 h at 
4ºC. Afterwards, the plate was washed with deionized 
water 4 times and dried completely. Fixed cells were 
stained with 100 µL of 0.057% sulforhodamine B 
(SRB) in 1% acetic acid for 30 min at room temperature. 
The plate was washed 4 times with 1% acetic acid 
and then allowed to dry up completely on the bench 
protected from light and dust. The bound dye was 
solubilised with 200 µL of 10 mM Tris base (pH 10.5) 
and the plate was shaken for 10 min at 200 rpm. The 
amount of protein in cells was determined by measuring 
the fluorescence of the dissolved dye at 488 and 585 nm 
as excitation and emission wavelengths, respectively, 
using a microplate reader (Synergy™ HT, Bio-Tek® 
Instruments, VT, USA). 
Cell staining and imaging for senescence-associated 
β-galactosidase 
The percentage of senescent cells was determined for 
each second passage with the senescence-associated β-
galactosidase (SA-β-gal) assay adopted from Tollefsbol 
[27] (Table II). 
Table II 
SA-β-gal assay protocol table 
Step Parameter Value Description 
1 Plate cells 1,000 µL 5,000 HDF cells in complete media, 24-well plate 
2 Incubation time 24 h 37°C, 5% CO2 
3 Ca2+- and Mg2+-free Dulbecco’s Phosphate 
Buffered Saline 
1,000 µL Wash cells 
4 3.7% formaldehyde solution 600 µL Fix cells 
5 Incubation time 5 min Ambient temperature 
6 Staining solution 600 µL pH 4.0, 5.2, 5.4, 5.6, each in triplicates 
7 Incubation time 20 h 37°C, air 
8 Taken pictures with microscope 4 images/well Inverted light microscope with camera 
Step notes: (1) Complete media: 10% foetal bovine serum, 2 mM L-glutamine, 1% MEM non-essential amino acid solution, 10 µg/mL 
gentamicin and 0.25 µg/mL amphotericin B in DMEM; (6) pH 4.0 is control. 
 
Fibroblasts were plated at 5.00 × 103 cells/well on 
24-well plates and incubated under the conditions 
described above. After 24 hours cells were washed 
with PBS, fixed with 3.7% formaldehyde solution for 
5 min at room temperature, washed with PBS and 
stained with the solutions at different pH values. 
The staining solution contained 1 mg/mL X-Gal (5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside), 
40 mM citric acid/sodium phosphate buffer (pH 4.0 - 
5.6), 5 mM potassium ferricyanide, 5 mM potassium 
ferrocyanide, 150 mM NaCl and 2 mM MgCl2. The 
well with the staining solution with pH 4.0 served as 
positive control, wells with pH 5.2 - 5.6 were used 
to identify senescent cells. The plate was incubated 
for 20 hours at 37ºC. Afterwards, several images were 
taken of each well using an inverted light microscope 
Leitz® Type 307-148.001 (Wetzlar, Germany) with 
attached camera. Stained (senescent) and unstained 
cells were counted in wells with pH 5.2, 5.4 and 5.6 
and the percentage of senescent cells calculated. 
Mitochondrial metabolism 
To evaluate mitochondrial metabolism during cell 
culture growth, the reduction of formazan by viable 
mitochondria was chosen, using XTT as the substrate 
[26] (Table III). 
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Table III 
XTT and SRB assays protocol table 
Step Parameter Value Description 
1 Plate cells 100 µL 20,000 HDF cells in double dilutions to 156 HDF cells in complete 
media, each in 6 replicates on a 96-well plate 
2 Incubation time 24 h 37°C, 5% CO2 
3 Ca2+- and Mg2+-free Dulbecco’s 
Phosphate Buffered Saline 
100 µL Wash cells 
4 Phenol red-free DMEM 100 µL Added assay medium 
5 XTT dye solution, freshly prepared 25 µL  
6 Incubation time 4 h 37°C, 5% CO2 
7 Assay readout 450/630 nm Measure absorbance of reduced XTT formazan product on 
microplate reader 
8 Incubation time 16 h 37°C, 5% CO2 
9 Ca2+- and Mg2+-free Dulbecco’s 
Phosphate Buffered Saline 
100 µL Wash cells 
10 Cold 10% trichloroacetic acid 100 µL Fix cells 
11 Incubation time 60 min 4°C 
12 Cold deionised water 4 x Wash cells 
13 Dry 24 h Ambient temperature 
14 SRB staining solution 100 µL Mix 10 s 
15 Incubation time 60 min Ambient temperature 
16 1% acetic acid 4 x Remove unbound SRB 
17 Dry 24 h Ambient temperature 
18 10 mM Tris base, pH 10.5 200 µL Solubilise bound SRB; 200 rpm, 5 min 
19 Assay readout 488/585 nm Measure fluorescence of SRB on microplate reader 
Step notes: (1) Complete media: 10% foetal bovine serum, 2 mM L-glutamine, 1% MEM non-essential amino acid solution, 10 µg/mL 
gentamicin and 0.25 µg/mL amphotericin B in DMEM; (4) Blanks: to 6 empty wells; (5) Composition of the XTT dye solution presented in 
text; (7) 450 nm test wavelength, 630 nm reference wavelength; (14) Composition of SRB staining solution presented in text. 
 
Cells were plated at densities 0.16 - 20.0 × 103 cells/ 
well under the conditions described above. After 24 
hours of incubation cells were washed with PBS and 
100 µL phenol red-free DMEM supplemented with 
10 µg/mL gentamicin and 0.25 µg/mL amphotericin 
B was added to reduce interference of red coloured 
pH indicator with absorbance measurements of orange-
coloured formazan product of XTT reduction. 25 µL 
XTT dye solution comprised of 1 mg/mL XTT and 
25 µM phenazine methosulfate in phenol red-free 
DMEM was added to each well. After 4 hours of 
incubation, the absorbance was read at 450 nm and 
630 nm as test and reference wavelengths, respectively, 
using a microplate reader (Synergy™ HT, Bio-Tek® 
Instruments, VT, USA). 
Data analysis 
The maximal growth rate was calculated from the 
linear phase of growth. Cell density (Ln) was plotted 
against days of growth for each second passage and 
linear regression was made from day 1 to day 3. The 
slope represents the maximal growth rate expressed 
as population doublings per day (PDL/day). The 
maximal growth rate and density at confluence for 
early passages were calculated as mean ± SD for 
passages 5, 7 and 9. Response curves for XTT and 
SRB assays were determined by linear regression 
through points for plating densities 6.25 - 10.0 × 103 
cell/well. For comparison between passages absorbance 
or fluorescence intensity, it was calculated for 
theoretical plating density 5.00 × 103 cell/well using 
the obtained response curves. The statistical significance 
of all trends was tested with linear regression analysis. 
Slope coefficients were expressed as confidence 
intervals. The confidence level was set to 95%. All 
statistical tests were conducted with the StatPlus:mac 
LE (Version v5), AnalystSoft Inc., Walnut, CA, USA 
software package for Microsoft Excel. 
 
Results and Discussion 
In our study, in vivo aged HDF from a 67-year old 
female donor were monitored during the first 35 
passages for the characteristics found in cells of older 
people, such as slower proliferation rate, pronounced 
contact inhibition and propagation of senescent cells 
compared with healthy adult cells. As shown in 
Figure 1, cells in middle and late passages were larger, 
but sparser than those in early passages, and with more 
prominent organelles. Additionally, cells in early 
passages are almost exclusively bipolar, thin and 
spindle-shaped. As they age in the culture they widen 
and outgrowths become more frequent. 
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Figure 1. 
Age-related changes in morphology of human dermal fibroblasts. Cells in passage 2 (A) are spindle-shaped and 
abundant. In passage 19 (B) some cells are wider and with outgrowths and in passage 35 (C) cells become as 
wide as long, with many outgrowths and are sparse. Scale bar represents 200 µm 
 
Maximal cellular growth rate in early passages (passages 
5 - 10) was 24 ± 2 h per population doubling and 
density at confluence was 7.7 ± 1.7 × 104 cells/cm2, 
which coincides with reported values for cells of older 
donors [16]. However, the average growth rate and 
density at confluence decreased (p < 0.001 and p = 
0.003) with the in vitro age of the culture. The drop 
in the course of 35 passages was approximately 4- 
and 3-fold, respectively (Figure 2). 
 
 
Figure 2. 
Two cell culture growth characteristics for first 35 passages of human dermal fibroblasts. Average growth rate 
(•) decreased at rate 0.014 ± 0.003 PDL/day/passage. Density at confluence (x), presented as mean ± SD of 
quadruplicate wells (n = 4) (values with RSD above 15% were omitted from the graph and calculations), 
decreased at rate 1.70 ± 1.01 × 103 cell/cm2/passage. Slopes were obtained by linear regression and confidence 
intervals were calculated at 95% confidence level 
 
Senescent cells were detected by the overexpression 
of senescence-associated β-galactosidase. The optimal 
pH for aged HDFs at which only senescent cells 
stained was 5.2 - 5.6. At lower pH, all cells stained, 
and at higher pH values, no cells coloured in blue. 
Senescent cells emerged continuously and steadily 
(p = 0.003) from 0 to 20% during the observation 
period of the first 35 passages. 
The linear range coinciding in both the XTT and 
SRB assays was 2 - 30 × 103 cell/cm2. The half 
maximal highest seeding density was chosen for 
evaluation to detect minimal declines in cell viability 
whilst being able to accurately determine boosts in 
viability. In the course of 15 passages, the metabolic 
activity of aged HDF declined (p = 0.003) for 75%. 
After freezing and thawing at passage 15, cells’ 
reduction ability increased to the early passage level 
and decreased (p = 0.002) with the similar rate as 
before. Cellular protein content more than doubled 
(p < 0.001) from the initial 0.5 ng/cell, a typical value 
for all human fibroblasts, regardless of in vivo age 
[16], and was unaffected by freeze-thawing the cells 
(Figure 3). 
 
FARMACIA, 2019, Vol. 67, 2 
 245 
 
Figure 3. 
Cell viability of human dermal fibroblasts as a function of the number of cell passages. Relative metabolic 
activity, measured by the XTT assay, decreased at similar rate before freezing (passages 3 - 15, 0.046 ± 
0.022/passage) and after thawing (passages 17 - 35, 0.043 ± 0.022/passage). Relative protein content, measured 
by the SRB assay increased at rate 84 ± 25 RFU/passage and freeze-thaw cycle did not have any impact. Values 
represent calculated fluorescence or absorbance for 5,000 cell/well from XTT (•) and SRB ( ) response curves, 
respectively, for each passage. Slopes were obtained by linear regression and confidence intervals were 
calculated at 95% confidence level 
 
Researchers have shown that the in vitro artificially 
aged culture model is appropriate for cell ageing 
research [15, 16, 28, 29]. Nevertheless, scientists are 
in favour of exploiting cells that have been originally 
aged in vivo, because growth conditions in culture 
differ from those in the living tissues considerably 
[15, 16, 26, 30]. Accordingly, cells from a donor 
aged 65 years old or more were chosen for this 
“naturally” aged cell culture model. This approach is 
also more efficient with regard to time and resources 
needed to age cells in artificial setting. In our study 
HDFs from a female Asian 67-year-old donor were 
identified as an appropriate aged cell culture model. 
All examined signs of ageing were in accordance 
with the expectations for in vivo aged fibroblasts. 
Senescent cells, as one of the markers of skin 
functionality impairment, were scarce in the first 
passages. Deficiency of senescent cells in very early 
passages is believed to be due to the cell extraction 
process from the tissue where only proliferating cells 
survive. Therefore, the senescence observed in the 
present study may be caused by stress introduced 
through in vitro culturing. However, since senescent 
cells are found in skin tissues of elderly donors [31], 
we believe the cell culture expressing senescent 
phenotype to the similar degree as in vivo aged cells 
represent a more reliable geriatric cell culture model. 
In order to confirm these findings, further research 
using additional markers for ageing such as telomere 
length or mitochondrial age are required.   
As the number of passages increases, cells adapt to 
the in vitro conditions and no longer resemble their 
in vivo state. Altered shape, increased protein content, 
slower proliferation and lower metabolic activity were 
detected over time in this study. Thus, passages 5 - 
10 of aged human dermal fibroblasts were found to 
mimic in vivo tissue of older adults to the greatest 
extent: senescent cells are consistently found in those 
passages at approximately 5% level, while none of 
the observed characteristics changed significantly 
during the first 10 passages (growth rate: p = 0.087, 
density at confluence: p = 0.434, metabolic activity: 
p = 0.064, protein content: p = 0.186). 
Moreover, Shen et al. [31] showed approximately 
3-fold difference in viability and 2-fold difference in 
SA-β-gal expression between HDFs from young (22 
years) and old (65 years) volunteers in similar passages. 
This suggests there is a vast difference between young 
and in vivo aged cells and highlights the need for a 
cell culture model that represents the population of 
interest. Furthermore, permeability of human endothelial 
cells increases as they age in culture or in tissue. This 
is partly due to the increased number of senescent cells 
leading to leaky junctions [18, 32]. This knowledge 
further strengthens the rationale to test novel drug 
delivery systems for older patients on an aged cell 
culture model. 
An important finding, and potential source of errors 
was that freeze-thaw cycles apparently reset cellular 
metabolic activity to the level of passage 0, although not 
affecting protein content and other parameters (growth 
rate, density at confluence and % senescent cells). 
Therefore, the robust and reproducible SRB assay is 
recommended for cell proliferation measurements 
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rather than the formazan-based assays, which measure 
metabolic activity only. If metabolic activity is not 
important for the study, then freeze-thaw cycles may 
be allowed. 
The presented methodology may serve as a basis for 
the preclinical assessment of safety and effectiveness 
of drugs alone or their delivery systems developed 
for geriatric populations. Both the selected cell line and 
the methods used are widely accessible and affordable, 
thus offering a robust and comparable culture for such 
protocols. Aged cell culture method holds promise 
in helping the pharmaceutical research to develop 
drug delivery systems tailored considering the age 
related physiological changes. In our future work, we 
will aim to provide a proof of the presented concept, 
for example by incubating young and old cell culture 
with a drug that is known to be absorbed at decreased 
rate with advancing age [33]. 
 
Conclusions 
We provide here a standardised cell culture protocol 
of naturally aged (> 65 years old) human dermal 
fibroblasts, which has application in the screening of 
drug delivery systems intended for geriatric patients. 
The protocol was characterised by the evolution of 
ageing parameters based on morphology, proliferation 
rate, mitochondrial metabolic activity, cell protein 
content and the senescence marker SA-β-gal. Passages 
5 - 10 of our selected aged human dermal fibroblasts 
were found to mimic in vivo tissue of older adults to 
the greatest extent and therefore in vitro tests must be 
performed within these limits for the results to be 
more relevant to geriatric patients. 
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